“IMMUNE CHECKPOINT INHIBITORS IN SOLID TUMORS: MECHANISMS, CLINICAL EFFICACY, BIOMARKER-GUIDED PATIENT SELECTION, AND IMMUNE-RELATED ADVERSE EVENTS”. Journal of Multidisciplinary Sciences and Innovations, vol. 5, no. 03, Mar. 2026, pp. 1709-14, https://doi.org/10.55640/.